Hextend (Hospira, Inc.)


Welcome to the PulseAid listing for the Hextend drug offered from Hospira, Inc.. This Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: HETASTARCH
SUBSTANCE NAME: HETASTARCH
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1999-03-31
END MARKETING DATE: 0000-00-00


Hextend HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHextend from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 6(g/100mL)
START MARKETING DATE: 1999-03-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-1555_aea5152b-6373-4a47-84f5-d9d499eaf7d3
PRODUCT NDC: 0409-1555
APPLICATION NUMBER: BN200952

Other HETASTARCH Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hospira, Inc.Hextend